HMGB1 in Systemic Lupus Erythematosus.

Frontiers in Immunology
Tianye LiuBetty Diamond

Abstract

The high-mobility group box 1 (HMGB1) has been shown to exert proinflammatory effects on many cells of the innate immune system. Originally identified as a nuclear protein, HMGB1 has been found to play an important role in mediating inflammation when released from apoptotic or necrotic cells as a damage-associated molecular pattern (DAMP). Systemic lupus erythematosus (SLE) is a disease of non-resolving inflammation, characterized by the presence of autoantibodies and systemic inflammation involving multiple organ systems. SLE patients have impaired clearance of apoptotic debris, which releases HMGB1 and other DAMPs extracellularly. HMGB1 activity is implicated in multiple disease phenotypes in SLE, including lupus nephritis and neuropsychiatric lupus. Elucidating the various properties of HMGB1 in SLE provides a better understanding of the disease and opens up new opportunities for designing potential therapeutics.

References

Sep 21, 1973·European Journal of Biochemistry·G H GoodwinE W Johns
Mar 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Beatriz Rendon-MitchellHaichao Wang
Dec 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Huan YangKevin J Tracey
Jan 13, 2004·Lupus·N J AbbottD E M Dolman
Aug 17, 2004·Immunity·Czeslawa KowalBruce T Volpe
Nov 9, 2004·Trends in Immunology·Alberto MantovaniMassimo Locati
May 26, 2005·European Journal of Immunology·Ingrid E DumitriuPatrizia Rovere-Querini
Jun 29, 2006·Arthritis and Rheumatism·Xiaoping QingChaim Putterman
Sep 19, 2006·Immunity·Jacques Banchereau, Virginia Pascual
Mar 21, 2007·Journal of Autoimmunity·Udo S GaiplMartin Herrmann
May 21, 2008·Lupus·L E MunozJ van der Vlag
Dec 10, 2008·The Journal of Experimental Medicine·Vilma UrbonaviciuteReinhard E Voll
Oct 9, 2009·Autoimmunity·Julie Gauley, David S Pisetsky
Aug 3, 2010·Archivum Immunologiae Et Therapiae Experimentalis·Yi LiWestley H Reeves
Oct 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Thomas W FaustPatricio T Huerta
Sep 29, 2011·Nature Reviews. Rheumatology·Mariana J Kaplan
Feb 22, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jonatan LefflerAnna M Blom
Oct 25, 2012·Proceedings of the National Academy of Sciences of the United States of America·Myoungsun SonBetty Diamond
Nov 8, 2012·Current Opinion in Immunology·Jinyoung ChoiJoe Craft
Jan 15, 2013·American Journal of Physiology. Lung Cellular and Molecular Physiology·Jean-Marc TadieJaroslaw W Zmijewski
Feb 5, 2013·Antioxidants & Redox Signaling·Christina JankoMartin Herrmann
Aug 3, 2013·Frontiers in Cellular and Infection Microbiology·Eva Brencicova, Sandra S Diebold
Oct 9, 2013·Nature Reviews. Rheumatology·Andras Perl
Nov 14, 2013·Pharmacology & Therapeutics·Domenica MusumeciDaniela Montesarchio
Jan 22, 2014·Nature Reviews. Immunology·Martin GuilliamsBart N Lambrecht
Jan 29, 2014·Proceedings of the National Academy of Sciences of the United States of America·Ben LuKevin J Tracey
Mar 13, 2014·Scandinavian Journal of Immunology·C ZhangY Zhang
Jan 3, 2015·Journal of Autoimmunity·Samantha A ChalmersChaim Putterman
May 24, 2015·Immunobiology·Diane Scott, Marina Botto
Jun 17, 2015·Journal of Immunology Research·Mudan LuSidong Xiong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis